The Phenobarbital Sodium Injection, cataloged under National Stock Number 6505-01-660-3315, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Hikma Pharmaceuticals Usa Inc.. Government technical data includes 10 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-660-3315 |
| Primary Part Number | NDC00641-0477-25 |
| Item Name | Phenobarbital Sodium Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Hikma Pharmaceuticals Usa Inc. |
| Status | ACTIVE |
| Controlled Substance Classification | SCHEDULE IV |
| Administration | INTRAMUSCULAR AND INTRAVENOUS |
| Primary Container Content Quantity | 1.0 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Type | VIAL |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Active Medicament Medicinal Strength | 130.0 MILLIGRAMS PHENOBARBITAL SODIUM ACTIVE INGREDIENT |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00641-0477-25 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1445419 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM163288 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-660-3315 is a Phenobarbital Sodium Injection, manufactured by Hikma Pharmaceuticals Usa Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-660-3315 has 1 manufacturer part number on file: NDC00641-0477-25 (Hikma Pharmaceuticals Usa Inc.).
Key specifications for NDC00641-0477-25: Controlled Substance Classification: SCHEDULE IV; Administration: INTRAMUSCULAR AND INTRAVENOUS; Primary Container Content Quantity: 1.0 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 10 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.